查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750820

中央研究实验室市场规模、份额、趋势分析报告：按服务、最终用途、地区、细分市场预测，2025-2030 年

Central Lab Market Size, Share & Trends Analysis Report By Service (Genetic Services, Biomarker Services, Microbiology Services), By End-use (Pharmaceutical Companies, Biotechnology Companies), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

中央研究实验室市场成长与趋势：

根据Grand View Research, Inc.的最新报告，全球中央实验室市场规模预计到2030年将达到50.4亿美元，2025年至2030年的复合年增长率为6.56%。

中央实验室业务外包是推动市场成长的关键因素。

中心业务营运外包是临床试验产业日益增长的趋势，预计将为中心实验室创造丰厚的商机。临床实验和申办者将约80%的中心实验室业务外包，并且更青睐能够提供端到端一体化服务的实验室。

近年来，由于疫情期间对製药业的关注度增加，研发投入激增。随着疫情进入第三年，科学研究投入增强了研发管线，多项临床试验也已启动。疫情期间，介入性研究活动稳定扩展。製药业开发了新的试验交付方法，以便在疫情期间管理正在进行的临床试验。

疫情也带来了新的成长机会，人们越来越关注 mRNA 疫苗的研发和 COVID-19治疗方法的探索。然而，样本处理、供应链和物流对于送到临床实验室的样本至关重要。这些样本高度敏感，需要快速的物流和温控，以保持样本的稳定性，以获得最准确的结果。

中小型中心实验室的兴起加剧了全球竞争。中小型中心实验室在亚太等开发中地区非常普遍。此外，新兴经济体进行临床试验的成本较低，这使得选择位于这些地区的中心实验室变得更加容易。这是因为它们的物流成本低，而且靠近施行地点。

中央研究实验室市场报告重点

  • 由于基因分析在临床试验中的重要性日益增加，预计预测期内基因服务领域将以最快的复合年增长率成长。
  • 策略性收购是影响市场动态变化的因素之一。例如，中大型企业进行收购是为了加强其全球扩张或进入新业务领域。
  • 按最终用途划分，製药公司在 2024 年占据最大的市场占有率，为 44.78%。
  • 由于糖尿病和癌症等疾病领域的个人化医疗相关的临床试验对基因检测的需求不断增加，预计到 2024 年北美将占据全球市场的主导地位，占有 40.82% 的份额。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

  • 市场区隔和范围
  • 市场展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
  • 市场驱动因素
    • 加大临床试验研发投入
    • 新药需求不断成长
    • 中央研究实验室业务外包
    • 降低药物研发成本
  • 市场限制因素分析
    • 物流和样品处理
  • 商业环境分析
    • SWOT分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
    • COVID-19影响分析

第四章中央研究实验室市场：按服务分類的估计和趋势分析

  • 中央研究实验室市场：服务波动分析
  • 遗传学服务
    • 中央遗传服务实验室市场，2018-2030
  • 生物标誌服务
    • 生物标记服务中心实验室市场（2018-2030）
  • 微生物学服务
    • 微生物学服务中心实验室市场（2018-2030）
  • 解剖病理学/组织学
    • 解剖病理学/组织学中心实验室市场（2018-2030）
  • 检体管理与储存
    • 2018-2030 年检体管理与储存中心实验室市场
  • 特种化学品服务
    • 2018-2030 年特用化学品服务中心实验室市场
  • 其他的
    • 其他中央研究实验室市场，2018-2030

第五章中央研究实验室市场：按最终用途的估计和趋势分析

  • 中央研究实验室市场：最终用途趋势分析
  • 製药公司
    • 製药公司市场，2018-2030
  • 生技公司
    • 生技公司市场，2018-2030
  • 学术研究所
    • 学术研究市场，2018-2030

第六章中央研究所市场：区域估计与趋势分析

  • 2023 年及 2030 年中央研究实验室各地区市场占有率
  • 北美洲
    • 2018-2030年北美中央实验室市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲中央实验室市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太中心实验室市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018-2030年拉丁美洲中央实验室市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018-2030年中东与非洲中央研究实验室市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 参与企业概况
  • 财务表现
  • 参与企业
    • 市场领导者
    • 中央研究实验室市场占有率分析，2023年
    • 公司简介
Product Code: GVR-4-68039-962-2

Central Lab Market Growth & Trends:

The global central lab market size is estimated to reach USD 5.04 billion by 2030, registering a CAGR of 6.56% from 2025 to 2030, according to a new report by Grand View Research, Inc. The outsourcing of central lab work is a significant factor driving the market growth.

Outsourcing central lab work is a rising trend in the clinical trial industry, which is expected to create lucrative business opportunities for central labs. The investigators and sponsors outsource ~80% of the central lab work and prefer the labs that provide end-to-end integrated services.

Investment in R&D has witnessed a surge in past years, which can be attributed to the enhanced focus on the pharmaceutical industry during the pandemic. As we enter the third year of the pandemic, investment in science has enhanced the pipeline and several clinical trials have been initiated. Over the pandemic, activity in interventional studies grew steadily. The pharmaceutical industry developed a new way of conducting trials for the management of ongoing clinical trials during the pandemic.

The pandemic has also created new growth opportunities, with an increasing focus on mRNA vaccine development and investigations for several COVID-19 treatment options. However, sample handling, supply chain, and logistics play a significant role in the sample sent to clinical labs. These samples are highly sensitive and require fast logistics with temperature control, thereby maintaining sample stability to get the most accurate results.

The rise of small- and medium-scale central laboratories is intensifying the competition globally. The presence of small- and medium-scale central labs is highly prominent in developing regions such as the Asia Pacific. These laboratories are becoming critical in the management of clinical trials globally owing to the availability of central laboratory services at 20%-35% lower prices, when compared to Europe and the U.S. Furthermore, the lower cost of conducting clinical trials in the developing economies facilitates the selection of central laboratories present in these regions, which can be attributed to lower logistic costs and presence near the trial location.

Central Lab Market Report Highlights:

  • The genetic services segment is anticipated to grow at the fastest CAGR over the forecast period, owing to the increasing significance of genetic analysis in clinical studies.
  • Strategic acquisitions are one of the factors influencing the changing dynamics of the market. For instance, players are acquired by medium and large-scale enterprises for enhancing their global reach and entering new business segments.
  • By end-use, the pharmaceutical companies held the largest market share of 44.78% in 2024, attributable to an increasing number of interventional studies and investment into research.
  • North America dominated the global market in 2024 with a share of 40.82%, the increasing need for genetic testing in clinical trials related to personalized healthcare in disease areas, such as diabetes & cancers.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Service Outlook
    • 2.2.2. End Use Outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Rising R&D investment in clinical trial
    • 3.4.2. Escalating demand for novel drugs
    • 3.4.3. Outsourcing of central lab work
    • 3.4.4. Reducing the cost of drug research
  • 3.5. Market Restraint Analysis
    • 3.5.1. Logistics and sample handling
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Central Labs Market: Service Estimates & Trend Analysis

  • 4.1. Central Lab Market: Service Movement Analysis
  • 4.2. Genetic Services
    • 4.2.1. Genetic Services Central Lab Market, 2018 - 2030 (USD Million)
  • 4.3. Biomarker Services
    • 4.3.1. Biomarker Services Central Lab Market, 2018 - 2030 (USD Million)
  • 4.4. Microbiology Services
    • 4.4.1. Microbiology Services Central Lab Market, 2018 - 2030 (USD Million)
  • 4.5. Anatomic Pathology/Histology
    • 4.5.1. Anatomic Pathology/Histology Central Lab Market, 2018 - 2030 (USD Million)
  • 4.6. Specimen Management and Storage
    • 4.6.1. Specimen Management and Storage Central Lab Market, 2018 - 2030 (USD Million)
  • 4.7. Special Chemistry Services
    • 4.7.1. Special Chemistry Services Central Lab Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Central Lab Market, 2018 - 2030 (USD Million)

Chapter 5. Central Labs Market: End Use Estimates & Trend Analysis

  • 5.1. Central Lab Market: End-Use Movement Analysis
  • 5.2. Pharmaceutical Companies
    • 5.2.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 5.3. Biotechnology Companies
    • 5.3.1. Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 5.4. Academic and Research Institutes
    • 5.4.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)

Chapter 6. Central Lab Market: Regional Estimates & Trend Analysis

  • 6.1. Central Lab Market Share By Region, 2023 & 2030
  • 6.2. North America
    • 6.2.1. North America Central lab market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. Reimbursement Scenario
      • 6.2.2.5. U.S. Central lab market, 2018 - 2030 (USD MILLION)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Reimbursement Scenario
      • 6.2.3.5. Canada Central lab market, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Competitive Scenario
      • 6.2.4.3. Regulatory Framework
      • 6.2.4.4. Reimbursement Scenario
      • 6.2.4.5. Mexico Central lab market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Central lab market, 2018 - 2030 (USD Million)
    • 6.3.2. Germany
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. Reimbursement Scenario
      • 6.3.2.5. Germany Central lab market, 2018 - 2030 (USD Million)
    • 6.3.3. UK
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Reimbursement Scenario
      • 6.3.3.5. UK Central lab market, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Reimbursement Scenario
      • 6.3.4.5. France Central lab market, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Reimbursement Scenario
      • 6.3.5.5. Italy Central lab market, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Reimbursement Scenario
      • 6.3.6.5. Spain Central lab market, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Reimbursement Scenario
      • 6.3.7.5. Denmark Central lab market, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Reimbursement Scenario
      • 6.3.8.5. Sweden Central lab market, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Reimbursement Scenario
      • 6.3.9.5. Norway Central lab market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Central lab market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Scenario
      • 6.4.2.5. Japan Central lab market, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Scenario
      • 6.4.3.5. China Central lab market, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. Regulatory Framework
      • 6.4.4.5. Reimbursement Scenario
      • 6.4.4.6. India Central lab market, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Reimbursement Scenario
      • 6.4.5.5. South Korea Central lab market, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Reimbursement Scenario
      • 6.4.6.5. Australia Central lab market, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Reimbursement Scenario
      • 6.4.7.5. Thailand Central lab market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Central lab market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Scenario
      • 6.5.2.5. Brazil Central lab market, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Scenario
      • 6.5.3.5. Argentina Central lab market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Central lab market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Scenario
      • 6.6.2.5. South Africa Central lab market, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Scenario
      • 6.6.3.5. Saudi Arabia Central lab market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Scenario
      • 6.6.4.5. UAE Central lab market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Scenario
      • 6.6.5.5. Kuwait Central lab market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant's overview
  • 7.2. Financial performance
  • 7.3. Participant categorization
    • 7.3.1. Market Leaders
    • 7.3.2. Central Lab Market Share Analysis, 2023
    • 7.3.3. Company Profiles
      • 7.3.3.1. ACM Global Laboratories
        • 7.3.3.1.1. Company Overview
        • 7.3.3.1.2. Financial Performance
        • 7.3.3.1.3. Product Benchmarking
        • 7.3.3.1.4. Strategic Initiatives
      • 7.3.3.2. LabConnect
        • 7.3.3.2.1. Company Overview
        • 7.3.3.2.2. Financial Performance
        • 7.3.3.2.3. Product Benchmarking
        • 7.3.3.2.4. Strategic Initiatives
      • 7.3.3.3. Cerba Research
        • 7.3.3.3.1. Company Overview
        • 7.3.3.3.2. Financial Performance
        • 7.3.3.3.3. Product Benchmarking
        • 7.3.3.3.4. Strategic Initiatives
      • 7.3.3.4. Eurofins Scientific
        • 7.3.3.4.1. Company Overview
        • 7.3.3.4.2. Financial Performance
        • 7.3.3.4.3. Product Benchmarking
        • 7.3.3.4.4. Strategic Initiatives
      • 7.3.3.5. Versiti (Cenetron)
        • 7.3.3.5.1. Company Overview
        • 7.3.3.5.2. Financial Performance
        • 7.3.3.5.3. Product Benchmarking
        • 7.3.3.5.4. Strategic Initiatives
      • 7.3.3.6. Medicover Integrated Clinical Services (MICS) (Synevo Central Labs)
        • 7.3.3.6.1. Company Overview
        • 7.3.3.6.2. Financial Performance
        • 7.3.3.6.3. Product Benchmarking
        • 7.3.3.6.4. Strategic Initiatives
      • 7.3.3.7. A.P. Moller Holding A/S (Unilabs)
        • 7.3.3.7.1. Company Overview
        • 7.3.3.7.2. Financial Performance
        • 7.3.3.7.3. Product Benchmarking
        • 7.3.3.7.4. Strategic Initiatives
      • 7.3.3.8. Ampersand Capital Partners (Pacific Biomarkers)
        • 7.3.3.8.1. Company Overview
        • 7.3.3.8.2. Financial Performance
        • 7.3.3.8.3. Product Benchmarking
        • 7.3.3.8.4. Strategic Initiatives
      • 7.3.3.9. Lambda Therapeutic Research Ltd
        • 7.3.3.9.1. Company Overview
        • 7.3.3.9.2. Financial Performance
        • 7.3.3.9.3. Product Benchmarking
        • 7.3.3.9.4. Strategic Initiatives
      • 7.3.3.10. CIRION BioPharma Research Inc.
        • 7.3.3.10.1. Company Overview
        • 7.3.3.10.2. Financial Performance
        • 7.3.3.10.3. Product Benchmarking
        • 7.3.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 3 Global Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 4 Global Central Lab Market, by Region, 2018 - 2030 (USD Million)
  • Table 5 North America Central Lab Market, by Country, 2018 - 2030 (USD Million)
  • Table 6 North America Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 7 North America Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 9 U.S. Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 10 Canada Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 11 Canada Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 12 Mexico Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 13 Mexico Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Europe Central Lab Market, by Country, 2018 - 2030 (USD Million)
  • Table 15 Europe Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 16 Europe Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Germany Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 18 Germany Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 UK Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 20 UK Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 21 France Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 22 France Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 23 Italy Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 24 Italy Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Spain Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 26 Spain Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 27 Denmark Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 28 Denmark Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 Sweden Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 30 Sweden Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Norway Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 32 Norway Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Central Lab Market, by Country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36 China Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 37 China Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 Japan Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 39 Japan Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 40 India Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 41 India Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 South Korea Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 43 South Korea Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 44 Australia Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 45 Australia Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46 Thailand Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 47 Thailand Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Latin America Central Lab Market, by Country, 2018 - 2030 (USD Million)
  • Table 49 Latin America Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 50 Latin America Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Brazil Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 52 Brazil Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 53 Argentina Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 54 Argentina Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 57 South Africa Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 58 South Africa Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61 UAE Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 62 UAE Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 63 Kuwait Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 64 Kuwait Central Lab Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Central Lab Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 PESTEL Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Global Central Lab Market: Service Movement Analysis
  • Fig. 15 Global Central Lab Market, by Genetic Services, 2018 - 2030 (USD Million)
  • Fig. 16 Global Central Lab Market, by Biomarker Services, 2018 - 2030 (USD Million)
  • Fig. 17 Global Central Lab Market, by Anatomic Pathology/Histology, 2018 - 2030 (USD Million)
  • Fig. 18 Global Central Lab Market, by Specimen Management & Storage, 2018 - 2030 (USD Million)
  • Fig. 19 Global Central Lab Market, by Special Chemistry Services, 2018 - 2030 (USD Million)
  • Fig. 20 Global Central Lab Market, by Others, 2018 - 2030 (USD Million)
  • Fig. 21 Global Central Lab Market: End Use Movement Analysis
  • Fig. 22 Global Central Lab Market, by Pharmaceutical Companies 2018 - 2030 (USD Million)
  • Fig. 23 Global Central Lab Market, by Biotechnology Companies 2018 - 2030 (USD Million)
  • Fig. 24 Global Central Lab Market, by Academic & Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 25 Regional Marketplace: Key Takeaways
  • Fig. 26 Regional Outlook, 2023 & 2030
  • Fig. 27 Global Central Lab Market: Region Movement Analysis
  • Fig. 28 North America Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 30 Canada Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 32 Europe Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 33 Germany Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 34 UK Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 35 France Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 36 Italy Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 37 Spain Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 38 Denmark Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 40 Norway Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 42 Japan Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 43 China Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 44 India Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 45 Australia Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 54 UAE Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait Central Lab Market, 2018 - 2030 (USD Million)